1. Purpose and Policies of IR Activities
Takara Bio Inc., engages in IR (Investor Relations) activities in order to further increase trust from shareholders and other investors through the timely, appropriate and impartial disclosure of information, and to subsequently increase the evaluation of its corporate value on the securities exchange market. Through accurate disclosure of information such as business results, financial information, management strategies, and business operations, the Company is working to establish transparent management systems, and has set a goal of building stronger bonds of trust with shareholders and other investors in the medium-to-long term.
2. Method and Content of Information Disclosure
The Company provides timely and appropriate disclosure of information based on the laws and regulations described in the Financial Instruments and Exchange Act and the Rules on Timely Disclosure of Corporate Information established by the Tokyo Stock Exchange, and is working to ensure that all investors participating in the market have equal access to information that can effect investment decisions. Disclosed information is publicized through TDnet (Timely Disclosure Network), which is provided by the Tokyo Stock Exchange, and when necessary is transmitted through the press by way of journalists. Also, when information is publicized through TDnet, the Company works to expediently post the same information on this IR website.
3. Forward-Looking Statements
The information available on this IR website may include forward-looking statements. Statements on this IR, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group companies represent forecasts of future results. While such statements are based on the conclusions of management according to information available at the time of writing, they reflect many assumptions and opinions derived from information that includes major risks and uncertainties. Accordingly, decisions should not be made entirely based on the information on forward-looking statements about business results.